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Abstract 
Historically, the main objective of cardiac rehabilitation (CR) as an exercise-based programme was to restore or 
improve patients regular physical activity after a cardiac event. Since then CR has evolved into a comprehensive 
secondary prevention programme, the objectives of CR, and indications and contraindications for its use have also 
developed in sophistication. Current CR programmes are designed to stabilise or even reverse the progression of 
heart disease by controlling all modifiable risk factors. They are also concerned with improving patients quality of 
life by restoring their wellbeing. All this should be achieved with the maximum safety levels to patients. The first 
part of this review details on how CR evolved from a simple exercise programme to a comprehensive secondary 
prevention programme in the past few decades. The second part sets an example of modern CR provision, pathway 
and guidelines in a top leading country in this field, the UK.  
Keywords: cardiac rehabilitation, secondary prevention, coronary artery disease 
1. Introduction 
In medicine, while saving a patients life is clearly vital, it is also important to attempt to help patients recover a 
good quality of life. Experiencing a heart attack or a hospital admission following a cardiac event can be very 
stressful and patients who suffer such a dramatic event will definitely need support to live with their new heart 
condition. In particular, they will need help to stay as healthy as possible and therefore reduce the risk of suffering 
another event. Knowing that coronary artery disease (CAD) is a long term and progressive condition, the concept 
of rehabilitation in cardiac care is that the recipients gain the knowledge and support necessary to live as normal a 
life as possible alongside their cardiac condition. 
Cardiac rehabilitation (CR) has been defined by various organisations and national entities and can be 
encompassed by: 
“The coordinated sum of activities required to influence favourably the underlying cause of cardiovascular 
disease, as well as to provide the best possible physical, mental and social conditions, so that the patients may, by 
their own efforts, preserve or resume optimal functioning in their community and through improved health 
behaviour, slow or reverse progression of disease” (BACPR, 2017). 
Traditionally, exercise training is known as the core component of CR. Current practices guidelines, however, push 
towards comprehensive rehabilitation and thus CRs regulating bodies drive programmes to add other 
components to optimise the reduction of risk factors and improve adherence to healthy behaviours among 
recipients. Those components include health education, advice on the reduction of cardiac risk factors and stress 
management. 
1.1 Historical Background to Cardiac Rehabilitation 
For centuries, bed rest was considered essential in the treatment of a disease, and mobility restrictions were 
imposed on most patients, and particularly patients with heart disease. This practice was not challenged until 1802 
when Heberden reported the observation of an angina patient who improved after sawing wood for half an hour a 
day (Didier, Bigand, Vinter, & Boucheix, 2010). Despite some evidence of the benefits of physical activity for 
heart patients, the misguided focus on bed rest persisted until chair therapy was introduced in the 1940s. A few 
years later, daily short walks of 3 to 5 minutes were allowed four weeks after the coronary event (Mampuya, 2012). 
Since then advances in clinical research have led to better ways of understanding heart disease management. 
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The accumulation of evidence of the benefits for cardiac patients of early physical activity started in 1953 when a 
study conducted by Morris and Heady showed that CHD was at least one third higher in light occupation workers 
compared to heavy occupation workers (MORRIS & HEADY, 1953). The decrease in CHD incidents was 
attributed to the extra physical activity performed by heavy occupation workers. In 1966, Saltin and co-workers 
conducted a study on five men, each 20 years of age, to compare the effects of three weeks of bed rest and eight 
weeks of intense physical exercise on the subjects physical condition. Regardless of its small sample size, this 
study, which was known as the Dallas Bed Rest and Training Study, enriched the early discussions and analyses 
of the positive impact of exercise and the detrimental effects of bed rest on subjects physical condition 
(McGavock et al., 2009). 
In the late 1970s, the concept of prescribing exercise therapy for post-MI patients began to gain momentum as it 
became increasingly clear that immobilisation and reduced activity results in poor long-term prognosis and 
survival (Lear & Ignaszewski, 2001). The establishment of the benefits of exercise therapy on patients prognosis 
led to a surge of interest in the effects of exercise therapy on morbidity and mortality rates which then revealed 
undeniable improvements. Since that time a large and growing body of literature has emerged to establish the 
physiologic basis of the benefits of exercise and this has led to the development of CR programmes. 
Nowadays, CR is a complex intervention that has eventually evolved from the emphasis on exercise therapy to 
become a comprehensive secondary prevention programme that provides patients with supervised exercise and 
education sessions to help them to recover and get back to as full a life as possible. CR has been proven to be as 
much a part of CAD treatment as medicines are. Unfortunately, the proven benefits of CR are not matched by a 
strong endorsement of CR in the cardiology community. The reason behind this reticence can be attributed to the 
development of powerful drugs and new therapeutic technologies that have made it difficult for CR to compete in 
its own right, since cardiologists are apparently attracted to the immediate and short-term results of these 
conventional direct medical interventions. Recent years, however, have seen increasingly rapid advances in the 
field of cardiology. These recent developments have led to a better understanding of heart disease management 
which is in turn reflected in a renewed interest in CR. Hopefully, the coming years will witness a rapid rise in CR 
utilisation rates.  
2. Modern Cardiac Rehabilitation 
Historically, the main objective of CR as an exercise-based programme was to improve patients regular physical 
activity after a cardiac event (Mampuya, 2012). Since CR has evolved into a comprehensive secondary prevention 
programme, the objectives of CR, and indications and contraindications for its use have also developed in 
sophistication. Current CR programmes are designed to stabilise or even reverse the progression of heart disease 
by controlling all modifiable risk factors. They are also concerned with improving patients quality of life by 
restoring their wellbeing. All this should be achieved with the maximum safety levels to patients. 
2.1 Objectives 
The main objective of CR continues to be helping recipients to regain their autonomy by improving regular 
physical activity after a cardiac event. Controlling the modifiable risk factors and therefore reducing the negative 
effects of CAD is another objective of CR. The term risk factor is defined by WHO as: 
any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or 
injury” (WHO, 2014). 
Obviously, the more risk factors a subject has for a specific disease, the greater the chance they have of acquiring 
that disease. In cardiology, there are modifiable risk factors (those that can be controlled) and unmodifiable risk 
factors (which cannot be changed). Unmodifiable risk factors for CAD include age, gender, ethnicity and family 
history. Although unmodifiable risk factors cannot be changed, making changes to patients lifestyles can 
significantly reduce the risk of acquiring CAD prematurely. Other characteristics that may lead to an increased 
chance of acquiring CAD include social, economic and cultural change (e.g. urbanisation). Stress and poverty are 
also other determinants of an increased chance of getting CAD (WHO, 2014). These characteristics and 
determinants are not direct causes of CAD but can be looked at as the causes of the causes. Modifiable risk 
factors that may have an adverse impact on the prognosis of CAD include: hypertension, hypercholesterolemia, 
diabetes, sedentary lifestyle, obesity and smoking (Montalescot et al., 2013). Curing or at least controlling these 
factors can significantly reduce the progression of CAD disease. 
A comprehensive CR programme should also educate recipients about their conditions so as to allow them to 
become responsible for their medical treatment and lifestyle changes and therefore achieve optimal outcomes 
(Mampuya, 2012). These education sessions should be delivered in a structured fashion for instance using 
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workshop-based teaching programmes delivered and by a skilled and experienced multidisciplinary team such as 
dietitians, psychologists, exercise specialists, etc. (BACPR, 2017). Anxiety and depression, for example, have 
been reported to be associated with lower exercise capacity, fatigue and sense of wellbeing (Mampuya, 2012). The 
use of a skilled and experienced psychiatrist to educate recipients about stress management and self-control tools 
can help recipients to have a better control of other risk factors. 
Lastly, CR programmes should aim to limit the physiological and psychological effects of heart disease by 
controlling disease symptoms and the side effects of medications. This should have a favourable impact on patients 
quality of life, making the benefits of CR more tangible to recipients and therefore encouraging them to complete 
the programme, foster healthy behaviours and thus achieve optimal outcomes (Dalal, Doherty, & Taylor, 2015). 
2.2 Indications 
The literature on CR has highlighted several patient groups that should benefit from joining a CR programme. 
Generally accepted indications for CR include: myocardial infarction (MI), coronary artery bypass graft (CABG), 
percutaneous coronary intervention (PCI), valve repair or replacement and angina. The recent trends in CR which 
encourage programme commissioners to tailor special programmes for special patient groups have widened the 
scope of CR to include patients with heart failure and heart transplants. Different countries allocate different 
resources into CR, however, and therefore the indications for CR may vary between countries. In the UK, the 
National Institute for Health and Care Excellence (NICE), Department of Health, British Association for 
Cardiovascular Prevention and Rehabilitation (BACPR), and wider European guidelines agree that the patient 
groups listed in (Table 1) will benefit from a CR programme (Dalal et al., 2015). 
 
Table 1. Patient groups who benefit from CR (Note 1) 
Indication Description 
ACS  Including STEMI, NSTEMI, and unstable angina; also all patients undergoing 
reperfusion (such as CABG, primary PCI and elective PCI). 
Heart Failure (HF) Patients with newly diagnosed chronic HF and chronic HF with a step change in clinical 
presentation. 
Heart surgery Heart transplant, ventricular assist device, intra-cardiac defibrillator, valve replacement or 
repair and cardiac resynchronisation therapy. 
Angina Patients with a confirmed diagnosis of exertional angina. 
 
2.3 Contraindications & Safety 
Contraindications for the use of CR are only concerned with the exercise aspect of the programme while all other 
parts of CR are considered relatively safe. Since the exercise in a CR programme is medically prescribed and 
supervised, the risks of CR are considered to be low, and most patients referred to CR are eligible to participate in 
the programme. Furthermore, the capacity of CR providers to tailor their programme to suite the medical needs of 
individual patients has reduced the contraindicated patient groups even further. Nonetheless, medically unstable or 
life threatening conditions are examples of patients who are not eligible to enrol in a CR programme (Thomas et al., 
2010). 
The literature on CR has highlighted a number of studies that have documented the safety of exercise in a CR 
programme. In 2007, the Americac Heart Association (AHA) issued a statement to discuss the potential 
complications of exercise in a CR programme. This statement has estimated the incidence of exercise-related 
cardiovascular complications in CHD patients as one cardiac arrest per 116,906 patient-hours of supervised 
exercise, one MI per 219,970 patient-hours of supervised exercise, one death per 752,365 patient-hours of 
supervised exercise and one major complication per 81,670 patient-hours of supervised exercise (P. D. Thompson 
et al., 2007).  
Another observational study from a French registry with a population of 25,000 patients has reported one cardiac 
incident per 50,000 hours of supervised exercise. This is equivalent to 1.3 cardiac arrests per million patient-hours 
(Pavy, Iliou, Meurin, Tabet, & Corone, 2006). A qualitative Japanese study surveyed 136 hospitals operating core 
phase CR amounting to 383,096 patient-hours of supervised exercise. The incident rate of all adverse events was 
12 per 383,096 patient-hours while life-threatening events (death, cardiac arrest, AMI and cardiac rupture) 
occurred at the rate of one per 383,096 patient-hours of supervised exercise. This is equivalent to 3.13 and 0.26 
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events per 100,000 patient-hours of supervised exercise respectively. 
Taken together, these results suggest that supervised exercise in a CR programme is generally safe. These findings 
can only be extended to CR programmes that are equipped to handle major emergency events such as cardiac arrest, 
however. In addition, it should be noted that subjects in the above studies are medically evaluated before enrolling 
in the programme which could decrease the number of incident rates. In general, all these considerations support 
safety in supervised exercise programmes but they should not be extrapolated to home based programmes.  
2.4 Cardiac Rehabilitation Benefits 
The benefits of CR for the indicated patient groups have been reviewed comprehensively in several systematic 
reviews and meta-analyses including seven Cochrane reviews. However, these benefits remain controversial in the 
modern era of statins and acute revascularisation. A recent systematic review and met-analysis of randomised and 
non-randomised studies has sought to assess the actual evidence of CR in the modern era of cardiology, the Cardiac 
Rehabilitation Outcome Study (CROS) review(Rauch et al., 2016). These benefits are the result of all components 
of a comprehensive multi-disciplinary CR programme. In this section, the benefits of a comprehensive CR 
programme will be outlined with brief supporting evidence from the literature.  
2.4.1 Mortality 
A 2016 Cochrane review and meta-analysis of 63 randomised control trials (RCT) with 14,486 participants with a 
median follow-up of 12 months showed that CR has a varied effect on mortality. In this review 47 trials with a total 
sample size of 12,455 subjects reported all-cause mortality. Reduction in all-cause mortality between control and 
intervention groups was not statistically significant in these studies (relative risk (RR): 0.96; 95% confidence 
interval (CI): 0.88 to 1.04). On the other hand, 27 trials (n = 7,469) reported cardiovascular mortality and showed 
a statistically significant reduction of cardiovascular mortality (RR: 0.74; 95% CI: 0.64 to 0.86). Twenty studies in 
this review reported both types of mortality and results in this sub-group were consistent with the overall 
meta-analysis results (all-cause mortality RR: 0.91, 95% CI: 0.82 to 1.01; cardiovascular mortality RR: 0.78, 95% 
CI: 0.67 to 0.90) (Anderson et al., 2016). 
Another systematic review and meta-analysis of 34 RCTs with a total pooled population of 6,111 subjects has 
revealed a reduction in all-cause mortality for CR patients compared to control groups by 26% (odds ratio (OR): 
0.74, 95% CI: 0.58 to 0.95). It also showed a reduction in cardiovascular mortality by 36% (OR: 0.64, 95% CI: 
0.46-0.88) (Lawler, Filion, & Eisenberg, 2011). Conversely, a UK based trial titled Rehabilitation after 
myocardial infarction trial (RAMIT) reported no significant difference in mortality between patients referred to 
rehabilitation and controls at two years follow up period (RR: 0.98, 95% CI: 0.74 to 1.30) or after 79years (RR: 
0.99, 95% CI: 0.85 to 1.15) (West, Jones, & Henderson, 2012). The negative findings of this trial can be attributed 
to the biased study design and failure to recruit a large enough sample size for the trial (< 1000 patient in each arm 
of trial). In fact, RAMIT was designed to measure the effectiveness of CR as provided in real life rather than if 
CR works (Doherty & Lewin, 2012). 
This section has attempted to provide a brief summary of the literature relating to the impact of CR on all-cause 
mortality and cardiovascular mortality. In general, it seems that enrolling in a CR programme can impact rates of 
mortality favourably. The inconsistency in the literature may be due to several reasons related to the included 
studies design such as study periods and population, duration of CR, intensity of CR or whether CR was delivered 
effectively. 
2.4.2 Hospital Admissions 
To date, the latest Cochrane systematic review has shown that the risk of hospital admission was reduced by 18% 
when comparing exercised-based CR with usual care (RR: 0.82; 95% CI: 0.70 to 0.96) (Anderson et al., 2016). 
This data is based on 15 RCTs with a population size of 3,030 patients. Another systematic review aiming to 
update a previously published Cochrane systematic review of exercise-based CR for heart failure patients, 
measured hospital admission as a CR outcome. This study systematically reviewed 33 trials with six or more 
months of follow-up and included only patients with reduced ejection fraction (<40%) and New York Heart 
Association class II and III (n= 4,740). The findings revealed a reduced risk of overall hospital admission (RR: 
0.75; 95% CI: 0.62 to 0.92) and heart failure-specific admission (RR: 0.61; 95% CI: 0.46 to 0.80) in patients who 
received comprehensive CR compared with no exercise controls (Sagar et al., 2015). A drawback of this study, in 
addition to the inclusion of old studies, was the inclusion of trials with relatively small sample sizes and short-term 
follow-up. This reflected on the number of hospital admissions reported by the majority of the included trials. 
The main two challenges in modern cardiology are cost and capacity. It can therefore be assumed that CR, by 
reducing the number of hospital admissions, is a significant tool in facing the challenges in modern cardiology. It 
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can thus also be said that the outcomes of CR go beyond the benefits to individuals and encompass improvements 
to the whole cardiac care system. 
2.4.3 Quality of Life and Psychological Wellbeing 
Two of the main objectives of a comprehensive CR programme are to improve the quality of life and the 
psychological state of the patient. Improvements in quality of life can be achieved through improvement in 
exercise performance (fitness) and through alleviation of symptoms, i.e. reducing chest pain, dyspnoea and fatigue 
(Mampuya, 2012). A Cochrane review of exercise-based CR for CHD patients reported 20 trials, with a total 
population of 5,060 subjects, assessing Health Related Quality of Life (HRQL) using a variety of validated generic 
or disease-specific outcome measures. Fourteen of the 20 trials (65%) documented an increase in HRQL in one or 
more domains in patients subsequent to a CR programme compared to controls. Within these 14 trials, five 
reported a higher level of HRQL in at least one-half of the subscales (Anderson et al., 2016). The authors of the 
Cochrane review, however, expressed the HRQL scores as mean differences and were unable to quantify the effect 
of the 14 trials together due to the heterogeneity among the included studies. 
This view is supported by another Cochrane systematic review that was conducted on heart failure patients. Sagar 
et al. (2015) reviewed a total of 18 trials which reported a validated HRQL measure. Thirteen of those 18 trials 
(72%) reported higher HRQL scores in patients following exercised-based CR programmes compared with control 
subjects (Sagar et al., 2015). This finding provides a valuable insight into the subject as all 13 trials used the same 
validated HRQL scoring measure, the disease-specific Minnesota Living with Heart Failure Questionnaire 
(MLHFQ). 
Another benefit of CR is to improve the psychological state of the patient by stress reduction and the enhancement 
of the overall sense of psychosocial wellbeing. A meta-analysis of 23 RCTs with a total population size of 3,180 
CAD patients was conducted to evaluate the impact of including a psychosocial component within a standard 
exercise-based CR programme. Patients who received psychosocial intervention showed greater reductions in 
psychological distress (with effect size differences of 0.34) (Linden, Stossel, & Maurice, 1996). An American 
observational study tried to assess improvements in depression in patients who developed heart failure due to CHD 
after receiving a comprehensive CR programme. Depressive symptoms were assessed at baseline and after CR by 
standard questionnaire (Kellner Symptom Questionnaire). In patients who completed CR (n= 151) depressive 
symptoms decreased by 40% post CR, from 22% to 13% (p < 0.0001). In addition, Depressed patients who 
completed CR had a 59% lower mortality (44% vs 18%, p < 0.05) compared to depressed dropout subjects (n= 38) 
(Milani, Lavie, Mehra, & Ventura, 2011). This study, however, suffers from the limited sample size, especially in 
the dropout subjects and also from using a questionnaire that is not well established for measuring depressive 
symptoms in clinical trials of depression. 
Furthermore, two observational studies, one British (n= 465,825) and one American (n= 635), reported 
improvements in anxiety and depression after CR (Abdulrahman Al Quait & Doherty, 2016; Lavie & Milani, 
2006). Although the main objective of both studies was to compare levels of improvement in a range of outcomes 
between young and old patients, varied improvements in anxiety and depression were evident post CR in both 
groups with younger patients achieving better outcomes. 
2.4.4 Cardiovascular Risk Profile 
Modern CR programmes are designed to provide a reduction in the modifiable cardiovascular risk factors. A 
systematic review and meta-analysis of 34 RCTs (n= 6,111) examined the effect of CR on modifiable risk factors. 
Overall, trials found a more favourable effect on the prevalence of risk factors among subjects who were 
randomised to CR compared with controls. The risk factors in which improvements were observed in the 
intervention groups in these trials were smoking cessation, blood pressure and total cholesterol, whereas changes 
in body weight were minimal in both groups (Lawler et al., 2011). 
Another systematic review and meta-analysis of 23 trials and a total population size of 3,180 (2,024 intervention 
subjects and 1,156 controls) CAD patients reported the impact of CR on selected modifiable risk factors. The 
findings revealed that patients who received CR showed a greater reduction in systolic blood pressure, heart rate 
and cholesterol level (with effect size differences of -0.24, -0.38, and -1.54, respectively) (Linden et al., 1996). 
These results must be interpreted with caution, however, since the effect of medical drugs such as statins and 
beta-blockers could not be excluded. 
In a large cohort retrospective observational study (n= 465,825) Al Quait & Doherty conducted an evaluation of 
nine patient outcomes pre and post CR. The outcomes reported in this analysis were Body Mass Index (BMI), 
waist size, total cholesterol, blood pressure, smoking, walking fitness, physical activity, anxiety and depression. 
gjhs.ccsenet.org Global Journal of Health Science Vol. 10, No. 2; 2018 
43 
 
Although the primary objective of the study was to determine if CR outcomes were influenced by age in CHD 
patients, undeniable improvements were documented in modifiable risk factors in both groups. This analysis 
revealed that elderly patients achieved better outcomes in body shape risk factors while younger patients achieved 
much better outcomes across a wider range of risk factors, in particular with regards to smoking cessation 
(Abdulrahman Al Quait & Doherty, 2016). 
3. Cardiac Rehabilitation in the UK 
The availability of CR and how it is organised varies across countries. This is mainly to do with differences in 
health policies and politics since different countries allocate different resources into the healthcare system. 
Resource allocation is largely dependent on the income of each country, with high income countries generally 
investing more in healthcare services, and therefore CR, than low income countries (Mampuya, 2012). Worldwide, 
the availability of CR is low compared to the benefits it offers, as only 38% of countries globally have CR 
programmes. More specifically, 68% of those programmes are allocated in high income countries, 28.2% in 
middle income countries and only 8.3% in low income countries (Turk-Adawi, Oldridge, Tarima, Stason, & 
Shepard, 2013). The provision, pathway and guidelines of CR can therefore be different across countries. 
3.1 History of Cardiac Rehabilitation in the UK 
The earliest attempt to promote CR in the UK goes back to the year 1970 when Groden and co-authors circulated a 
questionnaire to all active adult cardiologists of the British Cardiac Society to assess their attitude towards CR. 
With a 75% response rate, the survey revealed that 74.3% of cardiologists were in favour of developing special 
services for the rehabilitation of cardiac patients whereas 25.7% felt that such special services were not indicated 
(Groden, Semple, & Shaw, 1971). The same study, however, found just nine cardiologists were in a position to 
offer CR to their patients in a special CR centre. In 1989 the number of CR centres had risen to 99 and by the year 
1992 the BHF could identify 151 centres (Bethell, Turner, EJ, & Rose, 2000). This figure continues to rise and in 
the first NACR report in 2007, 312 UK programmes have been identified (NACR, 2016). 
Until the introduction of the first guidelines and audit standards in 1996, there had been no protocol for the 
provision of CR in the UK and there was no information on what most programmes did, nor who their subjects 
were (Bethell et al., 2000). Two years prior to the introduction of the first national guidelines, specifically in 
January 1994, Thompson and colleagues posted a survey to the senior nurse of 244 centres in England and Wales 
to determine the level of CR provision. With a 100% response rate the results showed that most programmes were 
based in hospitals (92%) and had been in operation for between three months and 17 years. Content-wise, 100% of 
the programmes were delivering education and supervised exercise sessions, 96% were delivering stress 
management sessions and 40% counselling (D R Thompson, Bowman, Kitson, de Bono, & Hopkins, 1996). In 
1997, the BACPR, which was then known as BACR and had been established in 1993, embarked on a three stage 
questionnaire survey designed to evaluate the quality of CR provision in the UK, promote record keeping and to 
measure CR outcomes (Bethell et al., 2000). Since then, research into CR in the UK has evolved and significant 
funding has been attracted from sources including the BHF, the Department of Health and the Medical Research 
Council (David R. Thompson, 1998). This has resulted in placing the UK into the top 2% of countries in Europe in 
CR uptake (NACR, 2016). 
In 2000, a target was set for England that, by 2002, 85% of MI, PCI and CABG patients should be invited to attend 
CR (NACR, 2007). To ensure that this target is met and that all established guidelines are adhered to, the National 
Audit of Cardiac Rehabilitation (NACR) was formally established in the 2005, led by Prof Bob Lewin, and the first 
national audit report was published in 2007. In 2013 the NACR, under Prof Dohertys leadership and supported by 
the BHF, took a significant step in transforming the aduit into a service improvement and quality assurance system 
where the ultimate beneciaries are CVD patients. Nowadays, the overall mean uptake to CR in the UK has 
achieved a significant milestone by reaching 50%. This improvement brings the UK into the top 2% of countries in 
Europe (NACR, 2016). 
3.2 Structure 
Traditionally, CR in the UK has been delivered by clinicians in supervised groups of patients in outpatient hospital 
clinics or community centres (Dalal et al., 2015). NICE clinical guidelines advise the National Health Service 
(NHS) on caring for people with specific conditions, such as heart disease, and the treatment they should receive, 
while the BACPR is an association that represents CR professionals in the UK and is responsible for setting the 
standards by which clinicians work. The NACR, funded by BHF and hosted by the University of York, collects 
comprehensive audit data to support the improvement and monitoring of CR services in terms of their uptake, 
quality and clinical outcomes. Since 2016, the BACPR works in conjunction with the NACR implemented a 
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national certification system which ensures that CR programmes in the UK are meeting minimum standards. The 
structure of NACR in the UK is illustrated in Figure 1. 
 
 
Figure 1. Structure of NACR in the UK (Note 2) 
3.3 Pathway 
Recent guidance from the UK Department of Health commissioning guide for CR refers to a six stage pathway of 
care that begins with patient presentation (diagnosis of a cardiac event) and is followed by identification for 
eligibility, referral and recruitment, baseline assessment and the development of a care plan, delivery of a 
comprehensive CR programme, the completion of a final CR assessment and then discharge and transition to long 
term management (Figure 2). 
 
 
Figure 2. Department of Health Commissioning Guide Six-Stage Patient Pathway of Care (Note 3) 
 
Each stage in this pathway is vital for CR uptake, adherence and outcomes and, overall, it should have an effect on 
long-term behavioural change leading to the desired health outcomes (BACPR, 2017).  
3.4 Standards 
Formal CR programmes vary between countries in terms of their delivery, intensity and duration. All programmes, 
however, are seeking the presentation of evidence-based best practice to provide effective prevention and 
rehabilitation services to their patients. As the association in charge of setting the standards by which CR clinicians 
work, BACPR continuously revises and updates CR standards in the UK.  
In the updated third edition of the BACPR Standards and Core Components (2017), these standards and core 
components have been reduced from seven to six with the aim of this reduction being to increase the emphasis on 
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measurable clinical outcomes, audit and certification (BACPR, 2017). The six standards for cardiovascular 
prevention and rehabilitation as issued by BACPR are: 
Standard One The delivery of six core components by a qualified and competent multidisciplinary team, led by a 
clinical coordinator. 
Standard Two Prompt identification, referral and recruitment of eligible patient populations. 
Standard Three Early initial assessment of individual patient needs which informs the agreed personalised goals 
that are reviewed regularly. 
Standard Four Early provision of a structured cardiovascular prevention and rehabilitation programme (CPRP), 
with a defined pathway of care, which meets the individual’s goals and is aligned with patient preference and 
choice. 
Standard Five Upon programme completion, a final assessment of individual patient needs and demonstration of 
sustainable health outcomes. 
Standard Six Registration and submission of data to the National Audit for Cardiac Rehabilitation (NACR) and 
participation in the National Certification Programme (NCP_CR). (BACPR, 2017). 
These revised standards and core components place health behaviour change and education at the very centre of 
CR programmes whilst placing equal emphasis on risk factor management and psychosocial health. Standard six, 
for instance, has been designed in order to ensure that CR programmes in the UK are meeting, or at least working 
towards, the minimum standards. 
3.5 Utilisation 
Existing research recognises the critical role played by CR in heart disease prevention. Despite the robust evidence 
of the clinical benefits and cost effectiveness of CR, utilisation rates vary widely worldwide, ranging from 20% to 
50% (Dalal et al., 2015). Different healthcare policies and CR delivery systems among countries may explain, at 
least partially, this variability (Mampuya, 2012). 
In the year 2000 England was set a target that, by 2002, 85% of MI, PCI and CABG patients should be invited to 
attend CR. The first NACR report in 2007, however, revealed that this target was far from being met on the ground: 
of the 152,417 new eligible cardiac patients in the year April 2005 to March 2006, only 65,012 received CR, 
around 40% (NACR, 2007). A few years later, the NHS England CVD strategy for 2015/16 set a target to increase 
CR uptake to 65% for patients admitted with CAD (NHS England Guideline 2014). The 2016 NACR report 
showed that the overall uptake of eligible patients in CR programs is only 50%, a 3% increase from 2015 and 5% 
increase from 2014 (NACR, 2016). Although current CR utilisation rates in the UK fall below national 
recommendations, however, they still far exceed those seen in other European countries, with an overall mean of 
30% (Humphrey, Guazzi, & Niebauer, 2014). In fact, with a 50% average CR uptake in 2016, CR programmes in 
the UK are among the highest uptake figures globally (NACR, 2016). 
To date, however, little research has been conducted in regards to CR utilisation in the growing PCI population and 
it is not clear what factors influence this. Figure 3 illustrates CR utilisation rates in PCI patients for the past six 
years in the UK. 
 
 
Figure 3. CR utilisation rates in PCI patients as measured by NACR 
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The graph shows that there has been a gradual increase in the number of patients starting CR over the years 
although the number of referred patients dropped starting from the year 2013. Figure 3 also reveals that the number 
of PCI procedures has increased from around 28,000 in 2011 to more than 41,000 patients in 2016 (46%). It also 
shows that the gap between those who start and those whom complete the programme is getting wider, however, 
this might be attributed in part to the fact that the quality of data entry in the NACR portal has improved in recent 
years. 
When CR utilisation rates are analysed in respect to the type of treatment received, more gaps can be seen. The 
NACR 2016 report has shown low uptake rates in patients following MI (39%) and elective PCI (45%) compared 
to the world-leading uptake rate in the CABG population (60%). This is of major concern when we realise that 
there were 92,445 PCI procedures carried out in the UK in 2012 compared to 16,791 CABG procedures 
(Townsend, Bhatnagar, Wilkins, Wickramasinghe, & Rayner, 2015). In other words, around 50,000 eligible CR 
patients were not offered CR to prevent further MI and the progression of CAD (NACR, 2014). Although NHS 
Englands CVD strategy for 2015/16 has an ambition to increase the uptake of CR to 65% for patients admitted 
with CAD, only a 2% increase in uptake has been recorded from the previous year (England & Guideline, 2014; 
NACR, 2015, 2016). Looking deep into the differences and into those factors that may contribute to low uptake 
rates might help inform future strategies to increase CR uptake (Al Quait & Doherty, 2017; Karmali et al., 2014). 
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